GRML Stock Summary and Trading Ideas (Greenland Mines | NASDAQ:GRML)

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.

What symbol and exchange does Greenland Mines shares trade?

Greenland Mines trades on the NASDAQ stock market under the symbol GRML.

What is Greenland Mines stock price doing today?

As of June 12, 2026, GRML stock price declined to $0.29 with 2,500,835 million shares trading.

What is Greenland Mines's Beta?

GRML has a beta of 4.08, meaning it tends to be more sensitive to market movements. GRML has a correlation of 0.39 to the broad based SPY ETF.

How much is Greenland Mines worth?

GRML has a market cap of $35.52 million. This is considered a Sub-Micro Cap stock.

What are the top ETFs holding Greenland Mines?

The top ETF exchange traded funds that GRML belongs to (by Net Assets): VXF.

What are the support and resistance levels for Greenland Mines (GRML)?

GRML support price is $.28 and resistance is $.33 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GRML shares will trade within this expected range on the day.